Assistant Professor of Psychiatry and Behavioral Sciences (Child and Adolescent Psychiatry) at the Stanford University Medical Center
Dr. Lawrence Fung is a scientist and psychiatrist specialized in autism spectrum disorder (ASD), and the father of a neurodiverse teenager with ASD. He is the director of the Stanford Neurodiversity Project, which strives to uncover the strengths of neurodiverse individuals and utilize their talents to increase innovation and productivity of the society as a whole. He directs the Neurodiverse Student Support Program, Neurodiversity at Work Program (recently funded by Autism Speaks), and Adult Neurodevelopment Clinic at Stanford. Dr. Fung is an assistant professor in the Department of Psychiatry and Behavioral Sciences at Stanford University. His lab advances the understanding of neural bases of human socio-communicative and cognitive functions by using novel neuroimaging and technologies. His team devise and implement novel interventions to improve the lives of neurodiverse individuals by maximizing their potential and productivity. For example, he is conducting a study to demonstrate that specialized employment programs such as Neurodiversity at Work program will result in higher retention rates and quality of life.
Clinical Professor, Psychiatry and Behavioral Sciences - Child and Adolescent Psychiatry
Grace Gengoux, Ph.D., BCBA-D, is a Clinical Professor, Director of the Autism Intervention Clinic, and the Well-being Director within Stanford University’s Department of Psychiatry and Behavioral Sciences. Along with colleagues at Stanford, Dr. Gengoux has written a new book focused on professional well-being and practical strategies to promote resilience for providers of mental health care. Dr. Gengoux is also a licensed clinical psychologist with expertise in training parents to promote the healthy development of social skills in their children and manage challenging behavior using positive behavioral approaches. Dr. Gengoux has published peer-reviewed journal articles and book chapters on treatments for autism. She has specialized training in Pivotal Response Treatment (PRT), having completed her doctoral studies under the mentorship of Drs. Robert and Lynn Koegel. Dr. Gengoux oversees the PRT group parent training program at Stanford, supervises postdoctoral fellows providing PRT clinical treatment, and has completed multiple clinical trials evaluating the effects of PRT on the social-communication competence of young children with autism. Dr. Gengoux serves as Associate Editor for the Journal of Positive Behavior Interventions and serves on the Board of Directors for AbilityPath, one of the largest non-profits serving individuals with developmental disabilities in San Mateo and Santa Clara Counties. Dr. Gengoux received her Ph.D. in Clinical Psychology from the University of California Santa Barbara and completed her clinical internship and postdoctoral fellowship at the Yale Child Study Center, before joining the Stanford University School of Medicine clinical faculty in 2010.
Rachael L. and Walter F. Nichols, MD, Professor and Professor, by courtesy, of Neurology
Dr. Menon is the Rachel L. and Walter F. Nichols, MD, Professor of Psychiatry and Behavioral Sciences and, Professor, by courtesy, of Neurology at Stanford University. Dr. Menon is director of the Stanford Cognitive and Systems Neuroscience Laboratory, which seeks to advance fundamental knowledge of human brain function and dysfunction, and to use this knowledge to help children and adults with psychiatric and neurological disorders. Research in Dr. Menon's lab emphasizes a tight integration of cognitive, behavioral, neuroscience and computational methodologies. Students and researchers in his lab come from a wide range of disciplines, including psychology, neuroscience, electrical and biomedical engineering, computer science, psychiatry, and neurology, to conduct research in a highly interdisciplinary setting. Dr. Menon received his BSc (Honors) in physics from the Indian Institute of Technology and his PhD in computer science from the University of Texas at Austin. He did a postdoctoral fellowship in neurophysiology at the University of California, Berkeley under the direction of Prof. Walter J. Freeman, III. He came to Stanford University as a Sinclair Foundation Research Fellow and joined the faculty in 2000. Over the past two decades, Dr. Menon’s research has led to major breakthroughs in our understanding of the architecture, function, and development of these large-scale distributed human brain networks. Dr. Menon and his team were among the first to discover that the human brain is organized into specialized and interacting networks of brain regions, which has resulted in a paradigm shift in how we investigate human brain function and cognition. Virtually every psychiatric and neurological disorder has been probed with the scientific framework Dr. Menon and his team first developed. This includes discovery of the default mode, frontoparietal, and salience networks, and their functions, which have led to elucidation of how deficits in access, engagement and disengagement of large-scale brain networks play a prominent role in psychopathology, providing novel insights into brain mechanisms underlying cognitive, affective, and social function and dysfunction that cut across multiple neurological and psychiatric disorders. Dr. Menon’s lab work has been cited over 68,000 times with an h-index of 107, and an i-10 index of 208 (Google Scholar). Dr. Menon is a ISI Highly Cited Researcher in Neuroscience (2013, 2014, 2015, 2016, 2017, 2018; ISI, Thompson Reuters), and in 2019 and 2020 he was named an ISI Highly Cited Researcher with Cross-Field impact.
Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator)
Dr. Parker is Associate Professor and Associate Chair of the Department of Psychiatry and Behavioral Sciences at Stanford University where she directs the Social Neurosciences Research Program and Chairs the Major Laboratories Steering Committee. Dr. Parker's research expertise is the biology of social functioning, with a particular interest in oxytocin and vasopressin signaling pathways. Her preclinical research program focuses on developing novel animal models; her clinical research program encompasses biomarker discovery and therapeutic testing in patients with neurodevelopmental and neuropsychiatric disorders. Dr. Parker received her undergraduate and graduate degrees from the University of Michigan and completed postdoctoral training at Stanford University. Dr. Parker joined the Stanford faculty in 2007. She is an Affiliate Scientist at the California National Primate Research Center, a Member of the American College of Neuropsychopharmacology, and a Kavli Fellow of the US National Academy of Sciences. Dr. Parker’s research program has been supported by multiple funding agencies including the NIH, the Simons Foundation, NARSAD, and the Weston Havens Foundation. Dr. Parker serves on the Editorial Board of Psychoneuroendocrinology, the scientific advisory board for the Stanford Autism Center at Packard Children’s Hospital, and on various national (e.g., NIH and NSF) and international (e.g., Medical Research Council) grant review committees. She has also participated as an invited expert at NIH and US National Academy workshops.